Form 4: Director Sells FORM Shares Under 10b5-1 Plan

FormFactor Director Sheri Rhodes sold 7,634 shares of common stock for approximately $92.61 per share under a pre-arranged trading plan.

Summary

• Sheri Rhodes, a Director of FormFactor Inc. (FORM), reported a sale of common stock.
• The transaction involved the disposition of 7,634 shares of common stock.
• The shares were sold at a price of $92.6085 per share.
• The transaction occurred on February 10, 2026.
• The sale was conducted pursuant to a Rule 10b5-1(c) trading plan, indicating it was pre-arranged.
• Following this transaction, Sheri Rhodes beneficially owns 10,356 shares of FormFactor common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is a routine insider transaction executed under a pre-arranged 10b5-1 plan, which mitigates any immediate negative interpretation regarding the company's future performance.

Negatives

• A director selling shares could be perceived negatively by some investors, although the sale was pre-planned under a 10b5-1 program.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider sales, particularly when executed under a Rule 10b5-1 trading plan, are a common practice for corporate insiders to manage personal finances, diversify portfolios, or address liquidity needs. Such pre-scheduled sales typically do not reflect a change in the insider's view of the company's immediate prospects or the broader industry trends, unlike unscheduled sales which might signal a more immediate sentiment.

Stakeholder Impact

• Shareholders may note the director's sale, but the 10b5-1 plan suggests it is a planned personal financial management action rather than a reaction to new company-specific information.

Key Dates

Recommendation

A single insider sale by a director, especially when conducted under a Rule 10b5-1 trading plan, is generally not considered a strong signal for a change in investment recommendation. These plans are established in advance and are often for personal financial planning purposes, not necessarily indicative of a negative outlook on the company's future. Investors should consider broader company fundamentals and market conditions rather than this isolated transaction.

Keywords

FormFactor, FORM, Insider Sale, Director Transaction, Sheri Rhodes, SEC Form 4, 10b5-1 Plan, Equity Sale